Innovative Approach Completed Enrollment 14 Months Ahead of Schedule on Adaptive Design Study

Challenges

The customer wanted to expand enrollment and revise the study from a Phase II study with 180 patients in Protocol Amendment 2 to a Phase IIb registration study with 564 patients in Protocol Amendment 3. Due to the timing of Amendment 3 finalization just prior to planned enrollment close under Amendment 2 and the increasingly rapid enrollment, the Syneos Health™ team developed an action plan to ensure that enrollment was seamless between the two amendments.

 

Click here to read about our innovative approach to enrollment

Contact Us
Call Our Team 

Phone: +1 919 876 9300
Fax: +1 919 876 9360
Toll-Free: +1 866 462 7373

Corporate Headquarters

3201 Beechleaf Court
Suite 600
Raleigh, NC 27604-1547